RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia.
Pham LT, Peng H, Ueno M, Kohno S, Kasada A, Hosomichi K, Sato T, Kurayoshi K, Kobayashi M, Tadokoro Y, et al. Biochem Biophys Res Commun. 2022 Sep 17; 621:74-79. Epub 2022 Jun 30.